An inside guide to unlocking clinical research in the UK

PART 1: Plan for clinical trial success

The UK has a proud history of being at the forefront of innovation and discovery, with world-class infrastructure available to support health and care research across the nation. And yet, for some commercial research organisations, realising research objectives – such as recruitment – is an ongoing challenge.

Addressing delays in trial delivery is vital to the UK’s continued success as a global leader in commercial research.

To help companies to unlock the full promise of commercial research opportunities in the UK, tools and services have been developed to help ensure the feasibility of NHS trials and give companies the confidence to plan, place and perform clinical research in the UK quickly and efficiently.

But how can life science organisations ensure that they are making the most of these resources and maximising the potential of commercial trials in the UK?

In this first of two-part webinar series, brought to you by the National Institute for Health and Care Research, industry experts will dive into the opportunities for commercial research in the UK. During this session, attendees will learn more about services available to support activities before protocols are finalised and find out how working in partnership with UK organisations can help unlock commercial research delivery.

Join us on Tuesday 21st March at 14:00 GMT/ 15:00 CET/ 10:00 EST as experts from NIHR and AstraZeneca delve into this with pharmaphorum.

About the panel

Louise Knowles, Deputy Director, Head of Research Capacity and Growth at the Department of Health and Social Care.
Louise has held a number of scientific policy and strategy roles within DHSC. She was previously a Foresight Researcher at the Government Office for Science and led a number of Research Programmes for the Food Standards Agency. She has a BSc(Hons) in Microbiology and Virology and an MSc in Public Health.

Professor William Rosenberg, Clinical Investigator and NIHR Deputy Medical Director
William brings a national, clinical point of view and shares his experiences as Clinical Investigator and how early engagement with specialist expertise can help tackle 'deliverability'

Karl Davison, Service & Partnerships Expert, NIHR
Karl has extensive knowledge of the NIHR planning and feasibility services and how they support life sciences companies with 'deliverability'

Sarah Durston, Senior Director, UK Country Head, Astra Zeneca
Sarah has ten years of experience working as UK Country Head with large Pharma/Biotech companies and over 38 years in the industry, accountable for the quality and delivery of trials across all therapy areas and phases in UK and Ireland. She has represented pharma on numerous national groups and via membership of various ABPI (Association of British Pharmaceutical Industry) project teams. Prior to working for AstraZeneca, Sarah held roles at: Amgen, Roche, Merck Sharpe & Dohme and Smith Kline & French.

Eloise McLennan, Deep Dive editor (moderator)
Eloise McLennan is the editor for pharmaphorum’s Deep Dive magazine. She has been a journalist and editor in the healthcare field for more than five years and has worked at several leading publications in the UK.